Key result
Addition of nisoldipine or nifedipine to atenolol improved exercise capacity at 2 hours post-dosing, but the effect was not maintained at 12 hours.
Why the study?
Does the addition of nisoldipine or nifedipine to atenolol improve exercise capacity and reduce ischemia in patients with chronic stable angina pectoris?
RCT (n=24)
Double-blind
Does the addition of nisoldipine or nifedipine to atenolol improve exercise capacity and reduce ischemia in patients with chronic stable angina pectoris?
The addition of nisoldipine 10 mg or nifedipine 20 mg twice daily to atenolol provides anti-ischemic benefits for less than 12 hours, suggesting more frequent dosing may be needed.
Answers are grounded in this paper and cite their sources.
May require more frequent dosing than twice daily for sustained benefit; confirms short duration of dihydropyridine action on atenolol.
The effects of the addition of slow-release nifedipine 20 mg twice daily and nisoldipine 10 mg twice daily to atenolol monotherapy were compared in a double-blind placebo-controlled study of 24 patients with chronic stable angina pectoris. Neither nisoldipine nor nifedipine was associated with significant subjective benefit at these doses. Two hours post-dosing, exercise capacity improved after both nisoldipine (duration + 37 s, P < 0.01; time to angina + 67 s, P < 0.01; time to significant ST depression + 60 s, P < 0.01) and nifedipine (duration + 21 s, ns; time to angina + 56 s, P < 0.05; time to significant ST depression + 49 s P < 0.05). However, this improvement was not maintained 12 h post-dosing. Ambulatory monitoring did not demonstrate a significant reduction in the amount of silent or total ischaemia following the addition of either nifedipine or nisoldipine to atenolol monotherapy. There was no significant difference between nifedipine and nisoldipine in any parameter tested. In conclusion, like slow-release nifedipine 20 mg, the effective duration of anti-ischaemic action of nisoldipine 10 mg is less than 12 h. Since several patients experienced vasodilatory unwanted effects, more frequent administration rather than larger individual doses may be desirable to achieve a clinical response.
No takes yet. Share an insight, caveat, or question.
Donaldson et al. (1993) conducted an RCT in chronic stable angina pectoris (n=24). Nisoldipine or nifedipine added to atenolol vs. Atenolol monotherapy (placebo) was evaluated on Exercise capacity 2 hours post-dosing (p=< 0.01). Addition of nisoldipine or nifedipine to atenolol improved exercise capacity at 2 hours post-dosing, but the effect was not maintained at 12 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: